1. British National Formulary. Gabapentin. 2025. Available at: https://bnf.nice.org.uk/drugs/gabapentin/. Accessed August 2025.
2. Electronic Medicines Compendium. SPC: Gabapentin 300mg capsules. 2019. Available at: https://www.medicines.org.uk/emc/product/2361/smpc. Accessed May 2025.
3. British National Formulary. Pregabalin. 2025. Available at: https://bnf.nice.org.uk/drugs/pregabalin/. Accessed August 2025.
4. Electronic Medicines Compendium. SPC: Pregabalin 150mg Capsules. 2017. Available at: https://www.medicines.org.uk/emc/medicine/30924. Accessed May 2025.
5. Electronic Medicines Compendium. SPC: Gabapentin 100mg capsules. 2019. Available at: https://www.medicines.org.uk/emc/medicine/26529. Accessed May 2025.
6. National Institute for Health and Care Excellence. Generalised anxiety disorder and panic disorder in adults: management. 2011. Available at: https://www.nice.org.uk/guidance/cg113.
7. Ashworth J, Bajpai R, Muller S et al. Trends in gabapentinoid prescribing in UK primary care using the Clinical Practice Research Datalink: an observational study. The Lancet Regional Health - Europe. 2023;27(no pagination). Available at: https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(22)00275-7/fulltext.
8. Schaffer AL, Busingye D, Chidwick K et al. Pregabalin prescribing patterns in Australian general practice, 2012-2018: a cross-sectional study. BJGP Open. 2021;5(1):1–10. Available at: https://pubmed.ncbi.nlm.nih.gov/33172853/.
9. Goodman CW, and Brett AS. A Clinical Overview of Off-label Use of Gabapentinoid Drugs. JAMA Internal Medicine. 2019;179(5):695–701. Available at: https://doi.org/10.1001/jamainternmed.2019.0086.
10. Montastruc F, Loo SY, and Renoux C. Trends in First Gabapentin and Pregabalin Prescriptions in Primary Care in the United Kingdom, 1993-2017. JAMA. 2018;320(20):2149–2151. Available at: https://doi.org/10.1001/jama.2018.12358. Accessed 2/10/2025.
11. National Institute for Health and Care Excellence. Low back pain and sciatica in over 16s: assessment and management (NG59). 2016. Available at: https://www.nice.org.uk/guidance/ng59. Accessed November 2025.
12. Enke O, New HA, New CH et al. Anticonvulsants in the treatment of low back pain and lumbar radicular pain: a systematic review and meta-analysis. Cmaj. 2018;190(26):E786–e793.
13. Giménez-Campos MS, Pimenta-Fermisson-Ramos P, Díaz-Cambronero JI et al. A systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica pain. Aten Primaria. 2022;54(1):102144.
14. Medicines and Healthcare products Regulatory Agency. Pregabalin (Lyrica), gabapentin (Neurontin) and risk of abuse and dependence: new scheduling requirements from 1 April. 2019. Available at: https://www.gov.uk/drug-safety-update/pregabalin-lyrica-gabapentin-neurontin-and-risk-of-abuse-and-dependence-new-scheduling-requirements-from-1-april. Accessed February 2025.
15. Medicines and Healthcare products Regulatory Agency. Pregabalin (Lyrica): reports of severe respiratory depression. 2021. Available at: https://www.gov.uk/drug-safety-update/pregabalin-lyrica-reports-of-severe-respiratory-depression. Accessed February 2025.
16. Medicines and Healthcare products Regulatory Agency. Gabapentin (Neurontin): risk of severe respiratory depression. 2017. Available at: https://www.gov.uk/drug-safety-update/gabapentin-neurontin-risk-of-severe-respiratory-depression. Accessed February 2025.
17. Medicines and Healthcare products Regulatory Agency. Improving Information Supplied with Gabapentinoids (Pregabalin/Gabapentin), Benzodiazepines and Z-Drugs. 2026. Available at: https://www.gov.uk/drug-safety-update/improving-information-supplied-with-gabapentinoids-pregabalin-slash-gabapentin-benzodiazepines-and-z-drugs?utm_source=Royal%20Pharmaceutical%20Society&utm_medium=email&utm_campaign=15319073_Drug%20Safety%20Update%3A%20Improving%20Information%20Supplied%20with%20Gabapentinoids%20%28Pregabalin%2FGabapentin%29%2C%20Benzodiazepines%20and%20Z-Drugs&utm_content=gov.uk%202&dm_i=EQ,94C9T,6137M4,126V9J,1. Accessed January 2026.
18. Oh G, Moga DC, Fardo DW et al. The association of gabapentin initiation and neurocognitive changes in older adults with normal cognition. Frontiers in Pharmacology. 2022;13:910719.
19. Hall TD, Shah S, Ng B et al. Changes in mood, depression and suicidal ideation after commencing pregabalin for neuropathic pain. Aust Fam Physician. 2014;43(10):705–708.
20. Psychopharmacology Committee of the Royal College of Psychiatrists, and British Association for Psychopharmacology. Gabapentinoids in psychiatric practice: Balancing the risks and benefits. 2025. Available at: https://www.rcpsych.ac.uk/improving-care/campaigning-for-better-mental-health-policy/position-statements/2025-position-statements/gabapentinoids-in-psychiatric-practice-(ps03-25). Accessed November 2025.
21. Medicines and Healthcare products Regulatory Agency. Pregabalin (Lyrica): findings of safety study on risks during pregnancy. 2022. Available at: https://www.gov.uk/drug-safety-update/pregabalin-lyrica-findings-of-safety-study-on-risks-during-pregnancy. Accessed May 2025.
22. National Institute for Health and Care Excellence. Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain. 2021. Available at: https://www.nice.org.uk/guidance/ng193/. Accessed February 2025.
23. Office for National Statistics. Deaths related to drug poisoning by selected substances. 2023. Available at: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/deathsrelatedtodrugpoisoninginenglandandwales/2023registrations#drug-poisonings-from-selected-substances. Accessed February 2025.
24. Electronic Medicines Compendium. SPC: Neurontin 100mg Hard Capsules. 2019. Available at: https://www.medicines.org.uk/emc/product/158. Accessed May 2025.
25. Electronic Medicines Compendium. SPC: Lyrica Capsules. 2019. Available at: https://www.medicines.org.uk/emc/medicine/14651. Accessed May 2025.
26. Electronic Medicines Compendium. SPC: Alzain 100 mg Capsules, Hard. 2019. Available at: https://www.medicines.org.uk/emc/medicine/30054. Accessed May 2025.
27. Kapil V, Green JL, Le Lait MC et al. Misuse of the γ-aminobutyric acid analogues baclofen, gabapentin and pregabalin in the UK. British Journal of Clinical Pharmacology. 2014(1365-2125 (Electronic)).
28. Evoy KE, Morrison MD, and Saklad SR. Abuse and Misuse of Pregabalin and Gabapentin. 2017(1179-1950 (Electronic)).
29. Clinical Guidelines on Drug Misuse and Dependence Update 2017 Independent Expert Working Group. Drug misuse and dependence: UK guidelines on clinical management. 2017. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/673978/clinical_guidelines_2017.pdf. Accessed May 2025.
30. Welsh Government. Welsh Health Circular. Advice for prescribers on the risk of the misuse of pregabalin and gabapentin. 2016. Available at: https://gov.wales/prescribing-guidance-pregabalin-and-gabapentin-whc2016030. Accessed May 2025.
31. Public Health England, and NHS England. Advice for prescribers on the risk of the misuse of pregabalin and gabapentin. 2014. Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/385791/PHE-NHS_England_pregabalin_and_gabapentin_advice_Dec_2014.pdf. Accessed May 2025.
32. Advisory Council on the Misuse of Drugs. Pregabalin and Gabapentin advice. 2016. Available at: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/491854/ACMD_Advice_-_Pregabalin_and_gabapentin.pdf. Accessed May 2025.
33. Faculty of Pain Medicine. Driving and Pain: Guidance for Faculty of Pain Medicine Members. 2019. Available at: https://www.fpm.ac.uk/sites/fpm/files/documents/2019-07/FPM-Driving-and-Pain-members-information.pdf. Accessed November 2025.
34. UK Government. Drugs and driving: the law. Available at: https://www.gov.uk/drug-driving-law. Accessed November 2025.
35. Driver and Vehicle Licensing Agency. Assessing fitness to drive: a guide for medical professionals. 2016. Available at: https://www.gov.uk/government/publications/assessing-fitness-to-drive-a-guide-for-medical-professionals. Accessed November 2025.
36. Live Well with Pain. Ask yourself six questions. 2025. Available at: https://livewellwithpain.co.uk/resource/ask-yourself-six-questions/. Accessed May 2025.
37. All Wales Medicines Strategy Group. Resources for pharmacological management of pain. 2023. Available at: https://awttc.nhs.wales/medicines-optimisation-and-safety/medicines-optimisation-guidance-resources-and-data/prescribing-guidance/resources-for-pharmacological-management-of-pain/. Accessed November 2025.
38. Soliman N, Moisset X, Ferraro MC et al. Pharmacotherapy and non-invasive neuromodulation for neuropathic pain: a systematic review and meta-analysis. The Lancet Neurology. 2025;24(5):413–428. Available at: https://doi.org/10.1016/S1474-4422(25)00068-7. Accessed 2026/01/27.
39. Welsh Government. Living with persistent pain in Wales. 2023. Available at: https://www.gov.wales/people-experiencing-persistent-pain-guidance. Accessed November 2025.
40. Moore RA, Straube S, Wiffen PJ et al. Pregabalin for acute and chronic pain in adults. Cochrane Database of Systematic Reviews. 2009(3):Cd007076.
41. Moore RA, Wiffen PJ, Derry S et al. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews. 2014;2014(4):Cd007938.
42. Finnerup NB, Attal N, Haroutounian S et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162–173.
43. National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Neuropathic pain - drug treatment: Gabapentin. 2025. Available at: https://cks.nice.org.uk/topics/neuropathic-pain-drug-treatment/prescribing-information/gabapentin/. Accessed November 2025.
44. National Institute for Health and Care Excellence. Clinical Knowledge Summaries: Neuropathic pain - drug treatment: Pregabalin. 2025. Available at: https://cks.nice.org.uk/topics/neuropathic-pain-drug-treatment/prescribing-information/pregabalin/. Accessed November 2025.
45. General Medical Council. Decision making and consent. 2020. Available at: https://www.gmc-uk.org/professional-standards/the-professional-standards/decision-making-and-consent. Accessed January 2026.
46. National Institute for Health and Care Excellence. NG215: Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults. 2022. Available at: https://www.nice.org.uk/guidance/ng215. Accessed January 2026.